Indisulam
CAS No. 165668-41-7
Indisulam ( E 7070;E7070 )
Catalog No. M12528 CAS No. 165668-41-7
Indisulam (E7070) is potent, sulfonamide, cell-cycle inhibitor that possesses antiproliferative activities, causes decrease in the S phase fraction along with G1 and/or G2 accumulation in various cancer cell lines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 34 | In Stock |
|
5MG | 55 | In Stock |
|
10MG | 77 | In Stock |
|
25MG | 125 | In Stock |
|
50MG | 198 | In Stock |
|
100MG | 298 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIndisulam
-
NoteResearch use only, not for human use.
-
Brief DescriptionIndisulam (E7070) is potent, sulfonamide, cell-cycle inhibitor that possesses antiproliferative activities, causes decrease in the S phase fraction along with G1 and/or G2 accumulation in various cancer cell lines.
-
DescriptionIndisulam (E7070) is potent, sulfonamide, cell-cycle inhibitor that possesses antiproliferative activities, causes decrease in the S phase fraction along with G1 and/or G2 accumulation in various cancer cell lines; causes blockade in the G1/S transition through inhibition of the activation of both cyclin-dependent kinase 2 and cyclin E, shows activity in multiple tumor types, most prominently in colon and lung cancer.Breast Cancer Phase 2 Discontinued
-
SynonymsE 7070;E7070
-
PathwayAngiogenesis
-
TargetCDK
-
Recptorcarbonicanhydrase;CDK
-
Research AreaCancer
-
IndicationBreast Cancer
Chemical Information
-
CAS Number165668-41-7
-
Formula Weight385.85
-
Molecular FormulaC14H12ClN3O4S2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 20mg/mL (< 1 mg/ml refers to the product slightly soluble or insoluble)
-
SMILESO=S(C1=CC=C(S(=O)(N)=O)C=C1)(NC2=CC=CC3=C2NC=C3Cl)=O
-
Chemical NameN-(3-chloro-7-indolyl)-1,4-benzenedisulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. van Kesteren C, et al. Br J Clin Pharmacol. 2002 Nov;54(5):463-71.
2. Owa T, et al. J Med Chem. 2002 Oct 24;45(22):4913-22.
3. Ozawa Y, et al. Eur J Cancer. 2001 Nov;37(17):2275-82.
4. Tsukahara K, et al. Mol Pharmacol. 2001 Dec;60(6):1254-9.
2. Owa T, et al. J Med Chem. 2002 Oct 24;45(22):4913-22.
3. Ozawa Y, et al. Eur J Cancer. 2001 Nov;37(17):2275-82.
4. Tsukahara K, et al. Mol Pharmacol. 2001 Dec;60(6):1254-9.
molnova catalog
related products
-
Amt-87
Amt-87 is a HIV latency-reversal agent that reactivates latent HIV at the transcriptional level, promotes phosphorylation of CDK9 T-loop at Thr186.
-
AT-7519
A potent CDK2 inhibitor with IC50 of 47 nM; also inhibits CDK1/4/5 with IC50 of 190/67/18 nM and shows selectivity over some kinases (Aurora A, IR kinase, MEK, PDK1, c-Abl, IC50>10 uM).
-
BI-1347
BI-1347 is a potent, selective inhibitor of CDK8/cyclinC with IC50 of 1 nM。